BioTime Is Running Out Of Time - Short-Sell Idea
Seeking Alpha
My hedge fund is short Biotime (BTX), a speculative "regenerative medicine" company. Biotime trades for a value of $221 million, but I think the company's enterprise is worth something closer to $20 million. With only $22 million in cash, ...


More...